US 10619154
Nuclease-mediated regulation of gene expression
granted A61KA61K2035/124A61K35/28
Quick answer
US patent 10619154 (Nuclease-mediated regulation of gene expression) held by Sangamo Therapeutics, Inc. expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2035/124, A61K35/28